Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a strong line-up of growth catalysts across GLP-1 drugs, contrast media, custom ...
India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...
Get all latest & breaking news on Murali K Divi. Watch videos, top stories and articles on Murali K Divi at moneycontrol.com.
Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...